These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1478368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [Abstract] [Full Text] [Related]

  • 6. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A, Manrique M, Arteaga A, Acosta AM, Andrade L.
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [Abstract] [Full Text] [Related]

  • 7. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I, Hummel M, Ziegler AG.
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [Abstract] [Full Text] [Related]

  • 8. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.
    Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE.
    Diabetes; 1994 Jun; 43(6):741-5. PubMed ID: 8194658
    [Abstract] [Full Text] [Related]

  • 9. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M, Nakamura N, Nakano K, Kondo M.
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract] [Full Text] [Related]

  • 10. Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitus.
    Avilés-Santa L, Maclaren N, Raskin P.
    J Diabetes Complications; 2004 Oct; 18(1):10-7. PubMed ID: 15019594
    [Abstract] [Full Text] [Related]

  • 11. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [Abstract] [Full Text] [Related]

  • 12. HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.
    Goday A, Motaña E, Ercilla G, Fernandez J, Gomis R, Vilardell E.
    Acta Diabetol Lat; 1990 Jun; 27(3):215-22. PubMed ID: 2075784
    [Abstract] [Full Text] [Related]

  • 13. Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes.
    Groop L, Groop PH, Koskimies S.
    Diabetologia; 1986 Nov; 29(11):757-60. PubMed ID: 3545954
    [Abstract] [Full Text] [Related]

  • 14. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
    Durinovic-Belló I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliott J, Roep BO, Karges W, Boehm BO.
    Diabetologia; 2004 Mar; 47(3):439-450. PubMed ID: 14745491
    [Abstract] [Full Text] [Related]

  • 15. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Akerblom HK, Knip M.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [Abstract] [Full Text] [Related]

  • 16. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R.
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [Abstract] [Full Text] [Related]

  • 17. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.
    Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK.
    Diabetologia; 1993 Nov; 36(11):1155-62. PubMed ID: 8270130
    [Abstract] [Full Text] [Related]

  • 18. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG, Eddouks M, Beylot M, Normand S, Boitard C, Feutren G, Landais P, Riou JP, Girard JR, Bach JF.
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [Abstract] [Full Text] [Related]

  • 19. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
    Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A.
    Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
    [Abstract] [Full Text] [Related]

  • 20. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.